Scholars Central

Case reportPublished 29 May 2024

Iatrogenic Alzheimer’s disease In Recipients Of Cadaveric PituitaryDerived Growth Hormone

Authors: Jordi Douaud

Department of Psychology, University of Turin, Turin, Italy

Journal of Neuroinfectious Diseases

Volume 15 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Iatrogenic Alzheimer’s disease (AD) refers to cases of Alzheimer’s disease caused inadvertently by medical treatment or diagnostic procedures. One significant source of iatrogenic AD has been linked to the administration of cadaveric pituitary-derived growth hormone (c-hGH) used in treating growth hormone deficiencies before synthetic alternatives became available. This case study explores the development of AD in individuals treated with c-hGH, highlighting the pathogenesis, clinical features, and preventive measures that have evolved in response to this medical history.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neuroinfectious Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neuroinfectious Diseases
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Jordi Douaud”